Clinical predictors of bioterrorism-related inhalational anthrax
- PMID: 15288744
- DOI: 10.1016/S0140-6736(04)16769-X
Clinical predictors of bioterrorism-related inhalational anthrax
Abstract
Limitation of a bioterrorist anthrax attack will require rapid and accurate recognition of the earliest victims. To identify clinical characteristics of inhalational anthrax, we compared 47 historical cases (including 11 cases of bioterrorism-related anthrax) with 376 controls with community-acquired pneumonia or influenza-like illness. Nausea, vomiting, pallor or cyanosis, diaphoresis, altered mental status, and raised haematocrit were more frequently recorded in the inhalational anthrax cases than in either the community-acquired pneumonia or influenza-like illness controls. The most accurate predictor of anthrax was mediastinal widening or pleural effusion on a chest radiograph. This finding was 100% sensitive (95% CI 84.6-100.0) for inhalational anthrax, 71.8% specific (64.8-78.1) compared with community-acquired pneumonia, and 95.6% specific (90.0-98.5) compared with influenza-like illness. Our findings represent preliminary efforts toward identifying clinical predictors of inhalational anthrax.
Comment in
-
Anthrax and bioterrorism: are we prepared?Lancet. 2004 Jul 31-Aug 6;364(9432):393-5. doi: 10.1016/S0140-6736(04)16779-2. Lancet. 2004. PMID: 15288719 No abstract available.
-
Clinical predictors of bioterrorism-related inhalational anthrax.Lancet. 2005 Jan 15-21;365(9455):214-5; author reply 215. doi: 10.1016/S0140-6736(05)17737-X. Lancet. 2005. PMID: 15652599 No abstract available.
-
Clinical predictors of bioterrorism-related inhalational anthrax.Lancet. 2005 Jan 15-21;365(9455):214; author reply 215. doi: 10.1016/S0140-6736(05)17736-8. Lancet. 2005. PMID: 15652600 No abstract available.
Similar articles
-
Discriminating inhalational anthrax from community-acquired pneumonia using chest radiograph findings and a clinical algorithm.Chest. 2007 Feb;131(2):489-96. doi: 10.1378/chest.06-1687. Chest. 2007. PMID: 17296652
-
Anthrax and bioterrorism: are we prepared?Lancet. 2004 Jul 31-Aug 6;364(9432):393-5. doi: 10.1016/S0140-6736(04)16779-2. Lancet. 2004. PMID: 15288719 No abstract available.
-
Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001.MMWR Morb Mortal Wkly Rep. 2001 Nov 30;50(47):1049-51. MMWR Morb Mortal Wkly Rep. 2001. PMID: 11808925
-
When bioterrorism strikes: diagnosis and management of inhalational anthrax.Semin Respir Infect. 2003 Sep;18(3):134-45. Semin Respir Infect. 2003. PMID: 14505276 Review.
-
Zoonosis update. Anthrax.J Am Vet Med Assoc. 2008 Jul 1;233(1):63-72. doi: 10.2460/javma.233.1.63. J Am Vet Med Assoc. 2008. PMID: 18593313 Review. No abstract available.
Cited by
-
Cost-effectiveness comparison of response strategies to a large-scale anthrax attack on the chicago metropolitan area: impact of timing and surge capacity.Biosecur Bioterror. 2012 Sep;10(3):264-79. doi: 10.1089/bsp.2011.0105. Epub 2012 Jul 30. Biosecur Bioterror. 2012. PMID: 22845046 Free PMC article.
-
Lethal factor and anti-protective antigen IgG levels associated with inhalation anthrax, Minnesota, USA.Emerg Infect Dis. 2014 Feb;20(2):310-4. doi: 10.3201/eid2002.130245. Emerg Infect Dis. 2014. PMID: 24447456 Free PMC article.
-
Biowarfare and bioterrorism.Crit Care Clin. 2013 Jul;29(3):717-56. doi: 10.1016/j.ccc.2013.03.015. Crit Care Clin. 2013. PMID: 23830660 Free PMC article. Review.
-
Anthrax lethal toxin induces cell death-independent permeability in zebrafish vasculature.Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2439-44. doi: 10.1073/pnas.0712195105. Epub 2008 Feb 11. Proc Natl Acad Sci U S A. 2008. PMID: 18268319 Free PMC article.
-
Plasma assisted decontamination of bacterial spores.Open Biomed Eng J. 2008 Jul 25;2:36-42. doi: 10.2174/1874120700802010036. Open Biomed Eng J. 2008. PMID: 19662115 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical